Vertiv VRT Expands Power Protection Portfolio with Launch of PowerUPS 100 Standby Series in North America
Warren Buffett Teases Tiny Purchase in March Berkshire Filing May Identify the Investment
SpaceX OpenAI FirstDay Trading Valuations Could Surpass Berkshire Hathaway Polymarket Traders Suggest
Fed Minutes Reveal Potential Rate Hikes if Inflation Persists Amid Geopolitical Tensions
PepsiCo Reportedly Plans Snack Price Hikes in Late June Bloomberg Indicates
Morgan Stanley Lowers MGE Energy Price Target Amid Utility Sector Weakness
ELLO Q3 2024 Earnings Solid Earnings Amid Quiet Quarter Stock Dips Slightly
RBC Bearings Q1 2026 Earnings EPS Surpasses Expectations by Nearly 8
LFT Q1 2026 Earnings EPS Miss Weighs on Market Sentiment
ROG Q1 2026 Earnings EPS Surpasses Estimates as Stock Gains
DBRG Q1 2026 Earnings EPS Misses Estimates Amid Mixed Market Response
ACTU Q1 2026 Earnings EPS Misses Estimates Amid PreRevenue Phase
Foremost Clean Energy FMST Pushes Higher Testing Key Resistance Zone
Marvell Technology Gains Momentum MRVL Approaches Key Resistance After 29 Rally
Coherus Oncology Inc CHRS Rises 255 Key Levels to Watch After Support Hold
Comstock Inc LODE Surges Nearly 5 as Bullish Momentum Builds
SOS Limited SOS Holds Steady at 108 as Key Support and Resistance Levels Remain in Play
Corpay Inc Q1 2026 Earnings EPS Beat Drives Modest Stock Gain
FFAI Q1 2026 Earnings Narrowed Losses Beat Estimates but No Revenue Reported and Stock Drops 981
SEER Q1 2026 Earnings Narrowly Beats EPS Estimates as Company Maintains Cost Discipline
HSBC Q1 2026 Earnings Modest EPS Beat Amid Stable Performance
TSAT Q1 2026 Earnings Significant EPS Miss as Revenue Details Remain Unavailable
WDS Q4 2025 Earnings Strong EPS Beat Amid Operational Strength
AI Technology Divides Filmmakers at Cannes Market Implications for Entertainment Sector
MARPS Q4 2025 Earnings Royalty Income Holds Steady Amid No Revenue Expectation
Celanese CE Slips 096 as Chemical Sector Faces Persistent Headwinds
WEBTOON Entertainment WBTN Q1 2026 Earnings EPS Beat Driven by Cost Controls Amid Revenue Uncertainty
PDS Biotechnology Q1 2026 Earnings Narrowed Loss Per Share and Clinical Progress Drive Positive Market Response
DTIL Q1 2026 Earnings EPS Misses Estimates as PreCommercial Biotech Advances Pipeline
MPLX Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds
ARDX Q1 2026 Earnings EPS Misses Estimates by 142 Revenue Not Disclosed
BJRI Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher
DFLI Q1 2026 Earnings EPS Misses Estimates Despite Stock Gain